Minireviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. May 28, 2023; 29(20): 3066-3083
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3066
Table 2 Clinical studies assessing the impact of hypothermic machine perfusion on ischemic type biliary lesions after liver transplantation
Ref.Study designGroup (n)DBD/DCDHOPE duration (median)Definition of ITBLFollow upITBL-intervention
ITBL-control
DCD
DBD
DCD
DBD
Schlegel et al[61], 2023RCTHOPE (85) vs SCS (85)DBD95.5 minNR12 moNA1/85 (1.2%)NA3/85 (3.5%)
Ravaioli et al[56], 2022RCTHOPE (66) vs SCS (69)DBD145 minNonspecifically provided: Biliary strictures; Biliary others12 moNA5/55 (9%)NA6/55 (11%)
van Rijn et al[52], 2021RCTD-HOPE (78) vs SCS (78)DCD132 minSymptomatic NAS diagnosed with the use of 6-mo cholangiography in the presence of a patent HA6 mo5/78 (6%)NA14/78 (18%)NA
Czigany et al[57], 2021RCTHOPE (23) vs SCS (23)DBD145 minBiliary complications (clinical; radiological)12 moNA4/23 (17%)NA6/23 (26%)
Patrono et al[60], 2022CohortD-HOPE (121) vs SCS (723)DBD138 minBiliary complications 3-mo cholangiography if clinically indicatedMedian 21.6 (D-HOPE) and 51.1 (SCS) moNA5/121 (4%)NA35/723 (5%)
Rayar et al[58], 2021CohortHOPE (25) vs SCS (69)DBD117 minNR12 moNA0/25 (0%)NA1/69 (1.5%)1
Muller et al[37], 2020CohortNRP (132) vs HOPE (93)DCD132 minNAS was defined as strictures with or without HA thrombosis or arterial complications. Median 20 (NRP) 28 mo (HOPE) mo2/32 (6.3%)NA4/32 (12.5%)NA
Ravaioli et al[59], 2020CohortHOPE (10) vs SCS (30)DBD132 minNR12 moNANPNANP
Schlegel et al[55], 2019CohortHOPE (50) vs SCS DBD (50) vs SCS DCD (50)Both120 minIschemic cholangiopathy defined radiologically, as intrahepatic or hilar BS and dilatations with patent HA5 yr4/50 (8%)NA11/50 (22%)1/50 (2%)
van Rijn et al[51], 2017CohortD-HOPE (10) vs SCS (20)DCD126 minNAS was defined as bile duct stenosis in the biliary tree as detected by ERCP or MRCP with clinical signs of cholestasis and/or cholangitis in the presence of a patent HA12 mo1/10 (10%)NA9/20 (45%)2NA